Although this study did not establish in vivo relevance for this pathway, future research involving combined treatment with SPOP inhibitors and necroptosis-inducing stimuli or anti-cancer drugs might enhance anti-cancer efficacy in chemoresistant cancer cells in in vivo models. The gene discussed is SPOP; the disease is cancer.